WCM Investment Management
NVO

WCM Investment Management’s Novo Nordisk NVO Stock Holding History

WCM Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.1M Buy
1,181,027
+370,030
+46% +$15.9M 0.1% 69
2026
Q1 		$28.6M Sell
810,997
-1,697,295
-68% -$80.4M 0.07% 73
2025
Q4 		$128M Sell
2,508,292
-223,890
-8% -$11.4M 0.26% 50
2025
Q3 		$152M Buy
2,732,182
+97,477
+4% +$5.71M 0.32% 42
2025
Q2 		$181M Sell
2,634,705
-1,501,152
-36% -$102M 0.41% 39
2025
Q1 		$287M Buy
4,135,857
+104,733
+3% +$8.65M 0.74% 38
2024
Q4 		$346M Buy
4,031,124
+40,475
+1% +$4.38M 0.81% 40
2024
Q3 		$482M Sell
3,990,649
-44,146
-1% -$5.89M 1.09% 35
2024
Q2 		$583M Sell
4,034,795
-43,002
-1% -$5.7M 1.38% 29
2024
Q1 		$524M Sell
4,077,797
-142,401
-3% -$17M 1.24% 32
2023
Q4 		$437M Sell
4,220,198
-2,308,713
-35% -$228M 1.21% 29
2023
Q3 		$594M Sell
6,528,911
-406,409
-6% -$35.8M 1.74% 18
2023
Q2 		$560M Sell
6,935,320
-69,444
-1% -$5.67M 1.67% 23
2023
Q1 		$557M Sell
7,004,764
-156,688
-2% -$11.1M 1.78% 19
2022
Q4 		$485M Sell
7,161,452
-372,514
-5% -$21.8M 1.62% 21
2022
Q3 		$378M Sell
7,533,966
-166,140
-2% -$8.9M 1.36% 21
2022
Q2 		$424M Buy
7,700,106
+1,998,684
+35% +$111M 1.52% 17
2022
Q1 		$317M Buy
5,701,422
+730,292
+15% +$37.5M 0.88% 33
2021
Q4 		$278M Buy
+4,971,130
New +$269M 0.63% 35
2017
Q1 		– Sell
-15,814
Closed -$284K – 144
2016
Q4 		$284K Sell
15,814
-18,460,728
-100% -$335M ﹤0.01% 164
2016
Q3 		$384M Buy
18,476,542
+917,498
+5% +$22.7M 4.38% 7
2016
Q2 		$472M Buy
17,559,044
+900,464
+5% +$24.7M 7.54% 3
2016
Q1 		$451M Buy
16,658,580
+1,005,756
+6% +$26.9M 7.02% 3
2015
Q4 		$455M Buy
15,652,824
+2,793,298
+22% +$77.3M 9.32% 2
2015
Q3 		$349M Sell
12,859,526
-538,446
-4% -$15.2M 8.7% 3
2015
Q2 		$367M Buy
13,397,972
+4,064,606
+44% +$114M 8.26% 2
2015
Q1 		$249M Buy
9,333,366
+1,216,220
+15% +$28M 5.04% 4
2014
Q4 		$172M Buy
8,117,146
+480,942
+6% +$10.7M 4.96% 8
2014
Q3 		$182M Sell
7,636,204
-725,260
-9% -$16.7M 5.61% 5
2014
Q2 		$193M Buy
8,361,464
+2,221,948
+36% +$49.1M 4.81% 2
2014
Q1 		$140M Sell
6,139,516
-5,091,514
-45% -$108M 5.02% 2
2013
Q4 		$41.5M Buy
11,231,030
+8,182,610
+268% +$143M 1.5% 20
2013
Q3 		$51.5M Buy
3,048,420
+43,350
+1% +$729K 2.69% 13
2013
Q2 		$46.9M Buy
+3,005,070
New +$50M 2.53% 13

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

WCM Investment Management's NVO Position: Q2 2026 in Review

WCM Investment Management increased its Novo Nordisk (NVO) stake by 46% in Q2 2026, buying an estimated $15.9M and bringing the position to 1,181,027 shares worth $57.1M. The position accounts for 0.1% of the portfolio, ranked #69.

WCM Investment Management first reported a position in NVO in Q2 2013 and has held it in 34 quarters since. The position peaked at $594M in Q3 2023. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • WCM Investment Management held 1,181,027 shares of Novo Nordisk worth $57.1M as of Q2 2026.
  • WCM Investment Management bought 370,030 Novo Nordisk shares in Q2 2026, an estimated $15.9M.
  • Novo Nordisk made up 0.1% of WCM Investment Management's portfolio in Q2 2026, its #69 holding.
  • WCM Investment Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 34 quarters since.
  • WCM Investment Management's Novo Nordisk position peaked at $594M in Q3 2023.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.